Search research articles
Contact Us
Filters
Showing results (71-80 of 122) with videos related to
Page
of 13
Sort By:
The Journal of Infectious Diseases
|
January 30, 2020
Blocking Entry of Hepatitis B and D Viruses to Hepatocytes as a Novel Immunotherapy for Treating Chronic Infections
Panagiota Maravelia, Lars Frelin, Yi Ni, et al.
Journal of Hepatology
|
February 16, 2019
A central hydrophobic E1 region controls the pH range of hepatitis C virus membrane fusion and susceptibility to fusion inhibitors
Dominic H Banda, Paula M Perin, Richard J P Brown, et al.
Journal of Virology
|
June 24, 2011
Development and application of hepatitis C reporter viruses with genotype 1 to 7 core-nonstructural protein 2 (NS2) expressing fluorescent proteins or luciferase in modified JFH1 NS5A
Judith M Gottwein, Tanja B Jensen, Christian K Mathiesen, et al.
Gut
|
August 17, 2022
Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections
Rani Burm, Panagiota Maravelia, Gustaf Ahlen, et al.
The Journal of Infectious Diseases
|
April 1, 2010
Challenge pools of hepatitis C virus genotypes 1-6 prototype strains: replication fitness and pathogenicity in chimpanzees and human liver-chimeric mouse models
Jens Bukh, Philip Meuleman, Raymond Tellier, et al.
Stem Cells (Dayton, Ohio)
|
March 4, 2014
Human skin-derived precursor cells are poorly immunogenic and modulate the allogeneic immune response
Joery De Kock, Philip Meuleman, Gordana Raicevic, et al.
Antiviral Research
|
January 8, 2017
Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy
Tanvi Khera, Daniel Todt, Koen Vercauteren, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 18, 2006
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
Brett D Lindenbach, Philip Meuleman, Alexander Ploss, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 26, 2009
Detection and characterization of a new metabolite of 17alpha-methyltestosterone
Oscar J Pozo, Peter Van Eenoo, Koen Deventer, et al.
Cells
|
March 25, 2022
Viral Interference of Hepatitis C and E Virus Replication in Novel Experimental Co-Infection Systems
Thomas Burkard, Nora Proske, Kathrin Resner, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 122) with videos related to
Sort By:
Page
of 13
The Journal of Infectious Diseases
|
January 30, 2020
Blocking Entry of Hepatitis B and D Viruses to Hepatocytes as a Novel Immunotherapy for Treating Chronic Infections
Panagiota Maravelia, Lars Frelin, Yi Ni, et al.
Journal of Hepatology
|
February 16, 2019
A central hydrophobic E1 region controls the pH range of hepatitis C virus membrane fusion and susceptibility to fusion inhibitors
Dominic H Banda, Paula M Perin, Richard J P Brown, et al.
Journal of Virology
|
June 24, 2011
Development and application of hepatitis C reporter viruses with genotype 1 to 7 core-nonstructural protein 2 (NS2) expressing fluorescent proteins or luciferase in modified JFH1 NS5A
Judith M Gottwein, Tanja B Jensen, Christian K Mathiesen, et al.
Gut
|
August 17, 2022
Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections
Rani Burm, Panagiota Maravelia, Gustaf Ahlen, et al.
The Journal of Infectious Diseases
|
April 1, 2010
Challenge pools of hepatitis C virus genotypes 1-6 prototype strains: replication fitness and pathogenicity in chimpanzees and human liver-chimeric mouse models
Jens Bukh, Philip Meuleman, Raymond Tellier, et al.
Stem Cells (Dayton, Ohio)
|
March 4, 2014
Human skin-derived precursor cells are poorly immunogenic and modulate the allogeneic immune response
Joery De Kock, Philip Meuleman, Gordana Raicevic, et al.
Antiviral Research
|
January 8, 2017
Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy
Tanvi Khera, Daniel Todt, Koen Vercauteren, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 18, 2006
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
Brett D Lindenbach, Philip Meuleman, Alexander Ploss, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 26, 2009
Detection and characterization of a new metabolite of 17alpha-methyltestosterone
Oscar J Pozo, Peter Van Eenoo, Koen Deventer, et al.
Cells
|
March 25, 2022
Viral Interference of Hepatitis C and E Virus Replication in Novel Experimental Co-Infection Systems
Thomas Burkard, Nora Proske, Kathrin Resner, et al.
Page
of 13